Gary Charles Robb - 24 Sep 2026 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 Sep 2026, 16:30:10 UTC
Prior SEC filing
18 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb

Key filing fact

Gary Charles Robb filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 28 Sep 2026.

Key facts

  • This page summarizes Gary Charles Robb's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 28 Sep 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 18 Sep 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001529655 Primary reporting owner

Robb Gary Charles

Relationship
Chief Business Officer
Address
C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb
Signature date
28 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORT transaction

Common Stock

Gift

Transaction value
Shares
-17,100
Change %
-55%
Price
$0.000000*
Shares after
14,056
Date
24 Sep 2026
Ownership
Direct
Footnotes
F1
CORT transaction

Common Stock

Gift

Transaction value
Shares
+5,000
Change %
+32%
Price
$0.000000*
Shares after
20,571
Date
24 Sep 2026
Ownership
Custodial Account for Child
Footnotes
F2
CORT transaction

Common Stock

Gift

Transaction value
Shares
+5,000
Change %
+32%
Price
$0.000000*
Shares after
20,571
Date
24 Sep 2026
Ownership
Custodial Account for Child
Footnotes
F3
CORT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
39,716
Date
24 Sep 2026
Ownership
Gary Charles Robb TTE Robb Revocable Trust
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 164 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Footnote F2

These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.

Footnote F3

These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.

Footnote F4

These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.

SEC remarks

The power of attorney under which this form was signed is on file with the Commission.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .